Back to Awarded Treatment Trials
Awarded Trial: 13T-016
Grant ID
13T-016
Illness
schizophrenia
Primary Drug/Intervention
aspirin
Primary Dosage
500 mg/b.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Weiser
Sample Size
160
Duration of Study Period for Each Subject
112 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Mark Weiser
Degree
MD
Center
N/A
Institution
Sheba Medical Center
Address
Tel Hashomer
City or Town
Ramat Gan
State or Province
N/A
Zip or Postal Code
52621
Country
Israel
Email Address
mweiser@netvision.net.il